Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kaitlyn Redling"'
Autor:
Kaitlyn Redling, David J. Chung, Wendy Schaffer, Alexander M. Lesokhin, Ioanna Tsakos, Nikoletta Lendvai, Sergio Giralt, Guenther Koehne, Heather Landau, Sean M. Devlin, Hani Hassoun, Patrick Hilden
Publikováno v:
Blood. 124:899-906
Standard carfilzomib (20 mg/m(2) cycle 1, 27 mg/m(2) thereafter; 2- to 10-minute infusion) is safe and effective in relapsed or refractory multiple myeloma (R/RMM). We report phase 2 results of carfilzomib 20 mg/m(2) on days 1 to 2 of cycle 1, 56 mg/
Autor:
Hani Hassoun, Ross L. Levine, David J. Chung, Minal Patel, Ahmet Dogan, Eric M. Sanford, Vincent A. Miller, Michelle Nahas, Sergio Giralt, Roman Yelensky, Doron Lipson, Mithat Gonen, Marcel R.M. van den Brink, Geoff Otto, Tim Brennan, Kristina W. Brennan, Kaitlyn Redling, Nikoletta Lendvai, Alexander M. Lesokhin, Heather Landau, Philip J. Stephens, Kai Wang, Guenther Koehne
Publikováno v:
Blood. 122:755-755
Background Patients with multiple myeloma (MM) have realized improved survival with the development of multi-drug combinations using immunomodulatory drugs (IMiDs), proteasome inhibitors, and alkylating agents. Nevertheless, all MM patients eventuall